White paper by the Society for CSF Analysis and Clinical Neurochemistry: Overcoming barriers in biomarker development and clinical translation
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
White paper by the Society for CSF Analysis and Clinical Neurochemistry: Overcoming barriers in biomarker development and clinical translation
Authors
Keywords
Society, Education Biomarkers, Neurology, Cerebrospinal fluid, Body fluids, Biomarker discovery, Assay development, Clinical implementation
Journal
Alzheimers Research & Therapy
Volume 10, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-03-15
DOI
10.1186/s13195-018-0359-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers
- (2017) Giovanni B Frisoni et al. LANCET NEUROLOGY
- Bridging the translational innovation gap through good biomarker practice
- (2017) Alain J. van Gool et al. NATURE REVIEWS DRUG DISCOVERY
- Neurofilament as a blood marker for diagnosis and monitoring of primary progressive aphasias
- (2017) Petra Steinacker et al. NEUROLOGY
- Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry
- (2017) Piotr Lewczuk et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- High diagnostic value of second generation CSF RT-QuIC across the wide spectrum of CJD prions
- (2017) Alessia Franceschini et al. Scientific Reports
- Concordance Between Different Amyloid Immunoassays and Visual Amyloid Positron Emission Tomographic Assessment
- (2017) Shorena Janelidze et al. JAMA Neurology
- Association of Plasma Neurofilament Light With Neurodegeneration in Patients With Alzheimer Disease
- (2017) Niklas Mattsson et al. JAMA Neurology
- The epigenome in Alzheimer’s disease: current state and approaches for a new path to gene discovery and understanding disease mechanism
- (2016) Hans-Ulrich Klein et al. ACTA NEUROPATHOLOGICA
- Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria
- (2016) Bruno Dubois et al. Alzheimers & Dementia
- Comparison of three analytical platforms for quantification of the neurofilament light chain in blood samples: ELISA, electrochemiluminescence immunoassay and Simoa
- (2016) Jens Kuhle et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Diagnostic Value of Cerebrospinal Fluid Biomarkers (Phospho-Tau181, total-Tau, Aβ42, and Aβ40) in Prodromal Stage of Alzheimer’s Disease and Dementia with Lewy Bodies
- (2016) Olivier Bousiges et al. JOURNAL OF ALZHEIMERS DISEASE
- Reference measurement procedure for CSF amyloid beta (Aβ)1-42and the CSF Aβ1-42/Aβ1-40ratio - a cross-validation study against amyloid PET
- (2016) Josef Pannee et al. JOURNAL OF NEUROCHEMISTRY
- CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis
- (2016) Bob Olsson et al. LANCET NEUROLOGY
- Genetic variations underlying Alzheimer's disease: evidence from genome-wide association studies and beyond
- (2016) Elise Cuyvers et al. LANCET NEUROLOGY
- Serum neurofilament light chain protein is a measure of disease intensity in frontotemporal dementia
- (2016) Jonathan D. Rohrer et al. NEUROLOGY
- Neurofilament Light Chain in Blood and CSF as Marker of Disease Progression in Mouse Models and in Neurodegenerative Diseases
- (2016) Mehtap Bacioglu et al. NEURON
- Plasma neurofilament light chain predicts progression in progressive supranuclear palsy
- (2016) Julio C. Rojas et al. Annals of Clinical and Translational Neurology
- Plasma Concentration of the Neurofilament Light Protein (NFL) is a Biomarker of CNS Injury in HIV Infection: A Cross-Sectional Study
- (2016) Magnus Gisslén et al. EBioMedicine
- A Multiplex Protein Panel Applied to Cerebrospinal Fluid Reveals Three New Biomarker Candidates in ALS but None in Neuropathic Pain Patients
- (2016) Anne-Li Lind et al. PLoS One
- Neurofilaments in blood and CSF for diagnosis and prediction of onset in Creutzfeldt-Jakob disease
- (2016) Petra Steinacker et al. Scientific Reports
- Neurofilament levels as biomarkers in asymptomatic and symptomatic familial amyotrophic lateral sclerosis
- (2015) Patrick Weydt et al. ANNALS OF NEUROLOGY
- Immunocapture strategies in translational proteomics
- (2015) Claudia Fredolini et al. Expert Review of Proteomics
- Body fluid biomarkers for multiple sclerosis—the long road to clinical application
- (2015) Charlotte E. Teunissen et al. Nature Reviews Neurology
- International consensus diagnostic criteria for neuromyelitis optica spectrum disorders
- (2015) Dean M. Wingerchuk et al. NEUROLOGY
- Progress in unraveling the genetic etiology of Parkinson disease in a genomic era
- (2015) Aline Verstraeten et al. TRENDS IN GENETICS
- The Central Biobank and Virtual Biobank of BIOMARKAPD: A Resource for Studies on Neurodegenerative Diseases
- (2015) Babette L. R. Reijs et al. Frontiers in Neurology
- A Practical Guide to Immunoassay Method Validation
- (2015) Ulf Andreasson et al. Frontiers in Neurology
- Cerebrospinal fluid biomarkers in trials for Alzheimer and Parkinson diseases
- (2014) Alberto Lleó et al. Nature Reviews Neurology
- β-site amyloid precursor protein-cleaving enzyme 1(BACE1) inhibitor treatment induces Aβ5-X peptides through alternative amyloid precursor protein cleavage
- (2014) Erik Portelius et al. Alzheimers Research & Therapy
- Disease duration and the integrity of the nigrostriatal system in Parkinson’s disease
- (2013) Jeffrey H. Kordower et al. BRAIN
- Immunosuppressive therapy reduces axonal damage in progressive multiple sclerosis
- (2013) Markus Axelsson et al. Multiple Sclerosis Journal
- Roadmap and standard operating procedures for biobanking and discovery of neurochemical markers in ALS
- (2012) Markus Otto et al. Amyotrophic Lateral Sclerosis
- Recommendations to standardize preanalytical confounding factors in Alzheimer’s and Parkinson’s disease cerebrospinal fluid biomarkers: an update
- (2012) Marta del Campo et al. Biomarkers in Medicine
- Cerebrospinal Fluid Collection Tubes: A Critical Issue for Alzheimer Disease Diagnosis
- (2012) A. Perret-Liaudet et al. CLINICAL CHEMISTRY
- Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
- (2012) Randall J. Bateman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Robust Central Reduction of Amyloid- in Humans with an Orally Available, Non-Peptidic -Secretase Inhibitor
- (2011) P. C. May et al. JOURNAL OF NEUROSCIENCE
- Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumab
- (2010) Martin Gunnarsson et al. ANNALS OF NEUROLOGY
- Biomarkers in Alzheimer's disease drug development
- (2010) Kaj Blennow NATURE MEDICINE
- Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
- (2009) Clifford R Jack et al. LANCET NEUROLOGY
- A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking
- (2009) C. E. Teunissen et al. NEUROLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started